Connection

Nicholas Pastis to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Nicholas Pastis has written about Radiopharmaceuticals.
Nicholas Pastis
Connection Strength
0.116
Radiopharmaceuticals
  1. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.